ArticleBMC cancer2022
Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with
Nicholas Fidelman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleBMC cancer2022
Nicholas Fidelman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.